Navigation Links
China Pharma Holdings, Inc. Reports Full Year 2009 Financial Results
Date:3/5/2010

2009 2008 Revenue $61,696,620 $50,968,660 Cost of revenue 36,046,259 25,678,239 Gross profit 25,650,361 25,290,421 Operating expenses Selling expenses 2,705,550 2,040,596 General and administrative expenses 2,147,081 1,671,715 Bad debt expense (benefit) (1,816,785) 1,847,806 Total operating expenses 3,035,846 5,560,117 Income from operations 22,614,515 19,730,304 Interest income 30,695 45,168 Interest expense (154,182) (131,027) Other income (expense) 3,540 (103,177) Income before income taxes 22,494,568 19,541,268 Provision for income taxes (2,261,519) (1,707,618) Net income 20,233,049 17,833,650 Other comprehensive income - foreign currency translation adjustment 183,189 2,880,314 Comprehensive income $20,416,238 $20,713,964 Basic and diluted earnings per share $0.48 $0.44 CHINA PHARMA HOLDINGS, INC. CONSOLIDATED STATEMENTS OF CASH FLOWS For the Years Ended December 31, 2009 2008 Cash Flows from Operating Activities Net income $20,233,049 $17,833,650 Depreciation and amortization 1,368,888 719,475 Bad debt expense (benefit)
'/>"/>
SOURCE China Pharma Holdings, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. China Biologic Products to Present at the Rodman & Renshaw Annual China Investment Conference
2. China Nepstar Chain Drugstore Reports Fourth Quarter and Fiscal Year 2009 Financial Results
3. China Nepstar Chain Drugstore Announces Annual Dividend
4. Chinas leading electronic systems design event to highlight next-generation medical, automotive and green power technologies
5. QRxPharma Limited and China Aoxing Pharmaceutical Company Announce Strategic Alliance for Development of MoxDuo(R)IV
6. OrbusNeich Announces First Patient Enrolled in Randomized Clinical Trial of Genous(TM) Bio-engineered R stent(TM) in China
7. Simcere Receives SFDA Approval to Manufacture and Sell Zanamivir in China
8. Candela Receives Registration Approval to Market Its Best-in-Class GentleMax and Alex TriVantage Lasers in China
9. Gorbec Pharmaceutical Services, Inc. Announces the Launch of Its GMP Analytical Laboratory in China
10. Chinas Basic Medical Insurance to Cover Sinobiopharmas Flagship Product
11. China Sky One Medical, Inc. Completes and Moves into New Corporate Headquarters
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... -- Regen BioPharma, Inc. (OTCBB: RGBP) and (PINK: ... of delivering its patented (US Patent 8,263,571) gene ... a clinically approved formulation as delivery system.  The ... silencing therapeutics in which the gene silencing drug ... By utilizing a local delivery system, potential toxicities ...
(Date:8/31/2015)... , Aug. 31, 2015  Soligenix, ... late-stage biopharmaceutical company developing products that address unmet ... and biodefense, announced today it has completed enrollment ... Data Review Committee (DRC) earlier this year, into ... is a first-in-class innate defense regulator (IDR) and ...
(Date:8/31/2015)... , Aug. 31, 2015  QT Vascular Ltd., together with ... together with its subsidiaries, the "Group"), a global ... of advanced therapeutic solutions for the minimally invasive ... results of the below-the-knee ("BTK") cohort of patients ... were presented on August 15, 2015 at the ...
Breaking Medicine Technology:Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 2Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 3Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 4Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 5Soligenix Announces Completion of Patient Enrollment into its Phase 2 Clinical Trial of SGX942 for the Treatment of Oral Mucositis in Head and Neck Cancer Patients 6Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 2Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 3Final Results From Below-The-Knee Cohort In Chocolate Registry Presented At The 5th Annual Amputation Prevention Conference 4
... levels were significantly higher in patients with osteosarcoma than ... Biological Trace Element Research (April 2009). Osteosarcoma, ... young adults.Randhu and colleagues measured serum fluoride levels in ... one had osteosarcoma, group two had non-osteosarcoma bone tumors, ...
... U.S. Agency for International Development (USAID) is convening a ... Ethiopia, in a regional exercise that will kick off ... The three-day exercise seeks to advance global capacity ... a pandemic. As recently emphasized by outbreaks of swine ...
Cached Medicine Technology:Another Study Links Fluoride to Bone Cancer 2USAID Cooperates in Pandemic Preparedness Initiative 2USAID Cooperates in Pandemic Preparedness Initiative 3
(Date:8/31/2015)... ... August 31, 2015 , ... MeYou Health ®, a social well-being company ... app, Walkadoo , by including an in-app step tracker. , Walkadoo is a ... walking habits. Rather than broadly assign every Walkadoo member 10,000 steps a day (as ...
(Date:8/31/2015)... ... August 31, 2015 , ... The ... the use of health IT to create efficiencies in healthcare information exchange, announces ... . Taking place at the Hyatt Regency Reston in Reston, Va. from October ...
(Date:8/31/2015)... ... August 31, 2015 , ... It’s a lot like ... director of GreenFields of Geneva. During his first days on the job, he’s run ... nice seeing them, and I like knowing that they’re living in such a wonderful ...
(Date:8/31/2015)... ... August 31, 2015 , ... The ... Talent Management Division , a department devoted to helping organizations identify and keep ... goes beyond selection, and The Brooks Group believes in offering a solution that ...
(Date:8/31/2015)... , ... August 31, 2015 , ... ... Commerce Exchange and Organization Supporting Business Owners and provided a tour of their ... Georgia, represents the success possible to international companies expanding business in the U.S. ...
Breaking Medicine News(10 mins):Health News:Walkadoo™ Walking Program Now Includes In-app Step Tracker 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 2Health News:WEDI Announces Program for Annual Fall Conference: WEDI-Con 2015 3Health News:Friendship Senior Options Welcomes New Executive Director for GreenFields of Geneva 2Health News:The Brooks Group Introduces Talent Management Division 2Health News:The Brooks Group Introduces Talent Management Division 3Health News:PartnerTech Supports Economic Growth as Host 2
... HealthDay Reporter , TUESDAY, Oct. 25 (HealthDay News) ... cantaloupes produced at a Colorado farm has reached 28, with ... late Tuesday. Officials said last week that the outbreak ... farm. Inspections on Sept. 22 and 23 ...
... potential leukemia therapy targets only cancer cells, while leaving ... cancer cells and healthy cells, causing significant side effects, ... This research is being presented at the 2011 ... Exposition in Washington, D.C., Oct. 23 27. ...
... both men and women, yet men remain underrepresented in research. A ... has found that the medical impact of the disorder is ... research has shown that the number of men seeking treatment is ... is closely linked to obesity and excessive weight gain as well ...
... high proportion of dense breast tissue, as seen with a ... But the role of non-dense fat tissue in the breast ... access journal Breast Cancer Research separates the breast ... shows that large areas of either are independently associated with ...
... TUESDAY, Oct. 25 (HealthDay News) -- Men with a history ... for lung cancer could benefit from a simultaneous check for ... estimated that smoking will cause more than 8 million deaths ... addition to cardiovascular disease and cancer, COPD is a major ...
... activity and cancer prevention, treatment recovery and survivorship have ... component in the treatment of a disease that claims ... to the American Cancer Society,s Global Facts and Figures. ... and Cancer, Dr. Kerry Courneya, is one of the ...
Cached Medicine News:Health News:Death Toll From Listeria Outbreak Hits 28 2Health News:Death Toll From Listeria Outbreak Hits 28 3Health News:Study shows why underrepresented men should be included in binge eating research 2Health News:CT Scans May Pick Up COPD Early in Smokers 2Health News:CT Scans May Pick Up COPD Early in Smokers 3Health News:Canada Research Chair renewal for Kerry Courneya 2Health News:Canada Research Chair renewal for Kerry Courneya 3
200 L, Bulk, yellow Recommended for 20, 25, 50, 100 and 200 L pipettes. Can also be used with 300 L pipettes when pipetting 200 L or less....
Capillary section fits into a 0.3-mm well for accurate loading of sequencing gels...
... Finntips have been designed to optimize the ... of our tip products is widely recognized ... range has been extended over the years ... standard and special tips including filter tips, ...
... order tips. Each box contains 10,000 tips ... in easy-to-open, re-sealable Bulk Packs of 200 ... with a tamper-proof strip which can easily ... Diamond Tips. Bulk Packs are closed using ...
Medicine Products: